| 000 | 01695 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516200204.0 | ||
| 264 | 0 | _c20141020 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1424-3911 | ||
| 024 | 7 |
_a10.1016/j.pan.2013.11.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiladi, Moshe | |
| 245 | 0 | 0 |
_aMitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields. _h[electronic resource] |
| 260 |
_bPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] _c |
||
| 300 |
_a54-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Size _xdrug effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aElectricity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMesocricetus |
| 650 | 0 | 4 |
_aMitosis _xdrug effects |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Stem Cell Assay |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aSchneiderman, Rosa S | |
| 700 | 1 | _aPorat, Yaara | |
| 700 | 1 | _aMunster, Mijal | |
| 700 | 1 | _aItzhaki, Aviran | |
| 700 | 1 | _aMordechovich, Daniel | |
| 700 | 1 | _aCahal, Shay | |
| 700 | 1 | _aKirson, Eilon D | |
| 700 | 1 | _aWeinberg, Uri | |
| 700 | 1 | _aPalti, Yoram | |
| 773 | 0 |
_tPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] _gvol. 14 _gno. 1 _gp. 54-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pan.2013.11.009 _zAvailable from publisher's website |
| 999 |
_c23573263 _d23573263 |
||